Dana-Farber Cancer Institute in Boston has partnered with St. Elizabeth's Medical Center in Brighton, Mass., to provide cancer care to St. Elizabeth's patients and provide access to clinical trials, according to a Boston Globe report.
Under the agreement, Dana-Farber will recruit physicians and other key personnel; advise St. Elizabeth's on care for complex patients and support services; and improve the hospital's IT system.
In turn, St. Elizabeth's, which is part of Boston-based Steward Health Care System, must follow Dana-Farber's treatment protocols for oncology patients and will pay Dana-Farber an undisclosed fee for its services. St. Elizabeth's is also investing $5.5 million to renovate the hospital's hematology and oncology unit as part of the agreement.
Study: Most Accelerated Partial Breast Irradiation Patients Unsuitable for Treatment
Study: Cancer Survivors Perceive Virtual Follow-up Visits Negatively
Under the agreement, Dana-Farber will recruit physicians and other key personnel; advise St. Elizabeth's on care for complex patients and support services; and improve the hospital's IT system.
In turn, St. Elizabeth's, which is part of Boston-based Steward Health Care System, must follow Dana-Farber's treatment protocols for oncology patients and will pay Dana-Farber an undisclosed fee for its services. St. Elizabeth's is also investing $5.5 million to renovate the hospital's hematology and oncology unit as part of the agreement.
Related Articles on Hospital Oncology:
Study: Robotic Surgery No Better Than Open Surgery for Prostate CancerStudy: Most Accelerated Partial Breast Irradiation Patients Unsuitable for Treatment
Study: Cancer Survivors Perceive Virtual Follow-up Visits Negatively